Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ImageneBio
AddedFeb 19, 2024
UpdatedJul 4, 2026
ImageneBio

ImageneBio

Public

Ikena: A targeted oncology firm developing novel therapies to combat cancer's formation and spread.

HQ
Boston, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Ikena Oncology is a targeted oncology company dedicated to developing novel cancer therapies that address key signaling pathways responsible for cancer growth and metastasis. The company's mission is to redefine the oncology landscape by creating differentiated therapies that target nodes of cancer growth, spread, and therapeutic resistance. Ikena envisions a world where every cancer patient has access to a cure, leveraging its institutional knowledge and advanced tools to develop the right drug using the right modality.

Ikena Oncology has made significant strides in the field of targeted cancer therapies, contributing to the advancement of treatments that offer hope to patients with limited options. The company's innovative approach and commitment to addressing unmet medical needs have positioned it as a leader in the oncology sector. Through strategic collaborations and a dedicated team of experts, Ikena continues to push the boundaries of cancer treatment, aiming to make a lasting impact on patient outcomes.

ImageneBio - Similar Companies

Revolution Medicines logo

Revolution Medicines

revmed.com

Traws Pharma logo

Traws Pharma

Clovis Oncology logo

Clovis Oncology

Kronos Bio logo

Kronos Bio

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

INmune Bio logo

INmune Bio

inmunebio.com

Curelab Oncology logo

Curelab Oncology

NiKang Therapeutics logo

NiKang Therapeutics

BeOne Medicines logo

BeOne Medicines

beigene.com

Oncofactor logo

Oncofactor

oncofactor.com

Cullinan Oncology logo

Cullinan Oncology

Umoja Biopharma logo

Umoja Biopharma

OncoPep logo

OncoPep

oncopep.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

ImageneBio - Quick Facts

Who are ImageneBio's competitors?

Companies similar to ImageneBio include Revolution Medicines, Traws Pharma, Clovis Oncology and Kronos Bio.

When was ImageneBio founded?

ImageneBio was founded in 2016.

Where is ImageneBio's headquarters located?

ImageneBio's headquarters is located in Boston, MA, US.

When was ImageneBio's last funding round?

ImageneBio's most recent funding round was for $40M (USD) in May 2023.

How much has ImageneBio raised to-date?

As of May 15, 2023, ImageneBio has raised a total of $209M (USD).

How many employees does ImageneBio have?

ImageneBio has 68 employees as of Feb 6, 2024.

ImageneBio - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapies
Tags
  • Healthtech
Unique IDs
  • secCik: 0001835579
  • ticker: IMA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research